Canadian General Investments: Investment Update - Unaudited

Wednesday, October 4, 2023
 
NEWS RELEASE TRANSMITTED BY GLOBENEWSWIRE
FOR: CANADIAN GENERAL INVESTMENTS, LIMITED
TSX: CGI
LONDON STOCK EXCHANGE: CGI
 
Canadian General Investments: Investment Update - Unaudited
 
TORONTO, CANADA – Canadian General Investments, Limited (CGI) reports on an unaudited basis that its net asset value per share (NAV) at September 30, 2023 was $54.29, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 14.0% and 22.1%, respectively. These compare with the 3.4% and 9.5% returns of the benchmark S&P/TSX Composite Index on a total return basis for the same periods.
 
The Company employs a leveraging strategy, by way of bank borrowing, with the intent to enhance returns to common shareholders. As at September 30, 2023, the leverage represented 15.4% of CGI’s net assets, up from 14.9% at the end of 2022 and down from 15.9% at September 30, 2022.
 
The closing price for CGI’s common shares at September 30, 2023 was $35.63, resulting in year-to-date and 12-month share price returns, with dividends reinvested, of 11.6% and 23.1%, respectively.
 
The sector weightings of CGI’s investment portfolio at market as of September 30, 2023 were as follows:
 

Information Technology

22.6%

Industrials

22.3%

Materials

15.7%

Energy

11.9%

Consumer Discretionary

11.2%

Financials

9.4%

Real Estate

4.4%

Communication Services

1.7%

Cash & Cash Equivalents

0.6%

Health Care

0.5%

The top ten investments which comprised 41.3% of the investment portfolio at market as of September 30, 2023 were as follows:

NVIDIA Corporation

6.9%

TFI International Inc.

4.7%

Canadian Pacific Kansas City Limited

4.4%

First Quantum Minerals Ltd.

4.4%

Franco-Nevada Corporation

4.0%

Apple Inc.

3.7%

West Fraser Timber Co. Ltd.

3.6%

WSP Global Inc.

3.4%

Mastercard Incorporated

3.2%

The Descartes Systems Group Inc.

3.0%
 
FOR FURTHER INFORMATION PLEASE CONTACT:
Jonathan A. Morgan
President & CEO
Phone: (416) 366-2931
Fax: (416) 366-2729